Urea Breath Test Market, by Test Type (Point-of-Care Tests (POCT) and Laboratory Based Test), by Product (Breath Analyzer and UBT- Kits), by Method (Mass Spectrometer, Infrared Spectrometer, and Laser Assisted Rationalizer), by End User (Hospitals, Clinic

Urea Breath Test Market, by Test Type (Point-of-Care Tests (POCT) and Laboratory Based Test), by Product (Breath Analyzer and UBT- Kits), by Method (Mass Spectrometer, Infrared Spectrometer, and Laser Assisted Rationalizer), by End User (Hospitals, Clinics, and Diagnostic Centers (Standalone Labs and Private Lab Networks)), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

There are various test for diagnosing H. pylori such as histopathological examination of the biopsy, immunohistochemical staining, rapid urease test, urea breath test (UBT), and stool antigen test (SAT).
However, the preference of urea breath test (UBT) over other tests is increasing, owing to its non-invasive nature. It is considered as the most accurate testing method among the non-invasive tests. This, in turn, will contribute to the growth of global urea breath test market.
Moreover, the test is found useful for both initial diagnosis of H. pylori and evaluating post treatment status. Hence, increasing its application throughout the course of H. pylori infection, is expected to further boost the market growth.

Market Dynamics

Researchers from several universities are developing & synthesizing substrates for conducting urea breath test which is expected to fuel the market growth over the forecast period. For instance, in 2018, the researchers from the University of São Paulo (CENA/USP) were successful in synthesizing and testing the 13C-enriched urea for Helicobacter pylori diagnosis and compared the results with other substrate produced abroad. Hence, such validation steps will increase the availability of the 13C-urea breath test in the country for efficient management of Helicobacter pylori infection
Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the global urea breath test market globally. For instance, in July 2021, Meridian Bioscience, Inc., a manufacturer of life science and diagnostic products, entered into a definitive agreement to acquire the BreathTek business from Otsuka America Pharmaceutical, Inc. The acquisition will enable Meridian Bioscience, Inc. to sell BreathTek, a urea breath test for the detection of H. pylori in North America. Hence, business development strategy will facilitate in strengthening the company’s position in providing gastrointestinal diagnostic solutions. Moreover, the company expects the acquisition of this business will facilitate in adding around US$ 20 million of annual revenue.

Key features of the study:
This report provides an in-depth analysis of global urea breath test market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global urea breath test market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co., Ltd., Fisher Analysen Methode GmbH (FAN), Avanos Medical, Inc., Beijing Binal Health Bio-Sci & Tech Co., Ltd, Kizlon Medical, and Gulf Coast Scientific, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global urea breath test market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global urea breath test market
Detailed Segmentation:
Global Urea Breath Test Market, By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
Global Urea Breath Test Market, By Product:
Breath Analyzer
UBT- Kits
Global Urea Breath Test Market, By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
Global Urea Breath Test Market, By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
Global Urea Breath Test Market, By Region:
North America
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country:
U.S.
Canada
Latin America
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country:
U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe
Asia Pacific
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific

Middle East
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country:
GCC
Israel
Rest of Middle East
Africa
By Test Type:
Point-of-Care Tests (POCT)
Laboratory Based Test
By Product:
Breath Analyzer
UBT- Kits
By Method:
Mass Spectrometer
Infrared Spectrometer
Laser Assisted Rationalizer
By End User:
Hospitals
Clinics
Diagnostic Centers
Standalone Labs
Private Lab Networks
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Mayoli Spindler (Kibion AB)*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
Otsuka Pharmaceutical Co. Ltd.
Sercon Group
Meridian Bioscience
Paladin Labs Inc.
Beijing Richen- Force Science & Technology Co., Ltd.
Fisher Analysen Methode GmbH (FAN)
Avanos Medical, Inc.
Beijing Binal Health Bio-Sci & Tech Co., Ltd
Kizlon Medical
Gulf Coast Scientific, Inc.

“*” marked represents similar segmentation in other categories in the respective section.